Incyte Corp (INCY)
70.39
-0.66
(-0.93%)
USD |
NASDAQ |
Nov 21, 16:00
70.35
-0.04
(-0.06%)
After-Hours: 20:00
Incyte Net Income (Quarterly): 106.46M for Sept. 30, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 106.46M |
| June 30, 2024 | -444.60M |
| March 31, 2024 | 169.55M |
| December 31, 2023 | 201.08M |
| September 30, 2023 | 171.27M |
| June 30, 2023 | 203.55M |
| March 31, 2023 | 21.70M |
| December 31, 2022 | 28.46M |
| September 30, 2022 | 112.78M |
| June 30, 2022 | 161.43M |
| March 31, 2022 | 37.99M |
| December 31, 2021 | 563.85M |
| September 30, 2021 | 181.74M |
| June 30, 2021 | 149.46M |
| March 31, 2021 | 53.54M |
| December 31, 2020 | 149.85M |
| September 30, 2020 | -15.20M |
| June 30, 2020 | 290.30M |
| March 31, 2020 | -720.64M |
| December 31, 2019 | 111.00M |
| September 30, 2019 | 128.27M |
| June 30, 2019 | 105.32M |
| March 31, 2019 | 102.31M |
| December 31, 2018 | 69.06M |
| September 30, 2018 | 29.18M |
| Date | Value |
|---|---|
| June 30, 2018 | 52.39M |
| March 31, 2018 | -41.14M |
| December 31, 2017 | -149.63M |
| September 30, 2017 | 36.05M |
| June 30, 2017 | -12.48M |
| March 31, 2017 | -187.08M |
| December 31, 2016 | 8.873M |
| September 30, 2016 | 36.88M |
| June 30, 2016 | 34.42M |
| March 31, 2016 | 24.05M |
| December 31, 2015 | 55.18M |
| September 30, 2015 | -39.58M |
| June 30, 2015 | 9.294M |
| March 31, 2015 | -18.36M |
| December 31, 2014 | -36.94M |
| September 30, 2014 | 59.29M |
| June 30, 2014 | -36.87M |
| March 31, 2014 | -33.96M |
| December 31, 2013 | -42.87M |
| September 30, 2013 | -22.04M |
| June 30, 2013 | -2.571M |
| March 31, 2013 | -15.67M |
| December 31, 2012 | 18.78M |
| September 30, 2012 | -21.71M |
| June 30, 2012 | 4.037M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-720.64M
Minimum
Mar 2020
563.85M
Maximum
Dec 2021
76.68M
Average
131.12M
Median
Net Income (Quarterly) Benchmarks
| Pfizer Inc | 4.465B |
| Biomarin Pharmaceutical Inc | 106.08M |
| Syndax Pharmaceuticals Inc | -84.13M |
| Allogene Therapeutics Inc | -66.29M |
| Arcutis Biotherapeutics Inc | -41.54M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 1.138B |
| Total Expenses (Quarterly) | 968.37M |
| EPS Diluted (Quarterly) | 0.54 |
| Enterprise Value | 11.91B |
| Gross Profit Margin (Quarterly) | 92.44% |
| Profit Margin (Quarterly) | 9.36% |
| Earnings Yield | 0.20% |
| Operating Earnings Yield | 0.04% |
| Normalized Earnings Yield | -0.2543 |